Bacterial flagella drive motility and chemotaxis while also playing critical roles in host-pathogen interactions, as their oligomeric subunit, flagellin, is specifically recognized by the mammalian immune system and flagellotropic bacteriophages. We recently discovered a family of phage-encoded, RNA-guided transcription factors known as TldR that regulate flagellin expression. However, the biological significance for this regulation, particularly in the context of host fitness, remained unknown. By focusing on a human clinical Enterobacter isolate that encodes a Flagellin Remodeling prophage (FRφ), here we show that FRφ exploits the combined action of TldR and its flagellin isoform to dramatically alter the flagellar composition and phenotypic properties of its host. This transformation has striking biological consequences, enhancing bacterial motility and mammalian immune evasion, and structural studies by cryo-EM of host- and prophage-encoded filaments reveal distinct architectures underlying these physiological changes. Moreover, we find that FRφ improves colonization in the murine gut, illustrating the beneficial effect of prophage-mediated flagellar remodeling in a host-associated environment. Remarkably, flagellin-regulating TldR homologs emerged multiple times independently, further highlighting the strong selective pressures that drove evolution of RNA-guided flagellin control. Collectively, our results reveal how RNA-guided transcription factors emerged in a parallel evolutionary path to CRISPR-Cas and were co-opted by phages to remodel the flagellar apparatus and enhance host fitness.
Dreampy is a Python implementation of the R dreamlet framework for pseudobulk differential expression analysis of single-cell RNA-seq data. dreamlet combines voom precision-weighted linear mixed models with empirical Bayes moderation to handle batch effects, repeated measures, and other hierarchical structure in multi-donor studies, but exists entirely within the R/Bioconductor ecosystem. dreampy reproduces this pipeline natively in Python, integrating with AnnData and the scverse ecosystem.
Interferons (IFNs) are synonymous with mobilizing cell-intrinsic defenses against microbial infection through the induction of interferon-stimulated genes (ISGs). Omics-based profiling has revealed that ISGs also dominate the transcriptional signature of a wide range of human disease conditions, including cancer, autoimmune and autoinflammatory disorders, and even normal aging. The ubiquity of the IFN signature means it is often interpreted as a biomarker for upstream inflammation, with little consideration given to how persistent ISG induction might influence downstream cellular and tissue physiology. However, the identification of endogenous targets for a growing number of ISG-encoded effectors has broadened our appreciation for the function of these genes—both in terms of how self-defense is achieved but also for the potential implications emanating from their prolonged induction. The same host-directed mechanisms that provide broad antimicrobial protection can, depending on context, either preserve tissue homeostasis or contribute to chronic inflammation and tissue dysfunction. In this perspective, we revisit the longstanding question of IFN causality in disease and argue that ISGs should be viewed as active participants in pathogenesis rather than passive markers of inflammatory activity. By examining disease-specific ISG expression patterns and synthesizing emerging evidence for the endogenous functions of ISGs, many of which converge on mitochondrial regulation, we propose a framework in which the composition of an IFN signature associated with a diseased tissue plays a major role in dictating whether inflammation is resolved or perpetuated.